BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Datacubed Health Names Leaders in Neurology, Genomics, Internal Medicine, Rare Disease and Psychiatry to Science Advisor Panel

  Datacubed Health today announced the appointment of its new Science Advisor Panel, consisting of world-renowned scientists and technologists spanning a wide and diverse range of fields.

  February 11, 2019

   · 

  4 min read
• Business

  Vitruvias Therapeutics Inc. Enters into a Semi-Solid (Topical) Licensing Agreement with Hong Kong-Based Bright Future

  Vitruvias Therapeutics Inc. has announced it has entered into a collaborative development agreement with a Hong Kong-based pharmaceutical company, Bright Future Pharmaceutical Lab Ltd, to develop a portfolio of semi-solids to be marketed in the United States and China.

  February 11, 2019

   · 

  3 min read
• Genetown

  Iron Mountain Showcases Digital Healthcare Expertise and Solutions in HIMSS 2019 Intelligent Health Pavilion

  Iron Mountain’s Cloud and secure IT asset destruction solutions featured in Intelligent Health Pavilion (IHP) exhibition areas (IHP booth #8559-30)

  February 11, 2019

   · 

  4 min read
• Business

  Centene Corporation Announces Envolve Center Name Change To The Centene Center for Health Transformation

  Centene Corporation announced that the Envolve Center for Health Behavior Change, a community-corporate-academic healthcare partnership between Centene, Washington University in St.

  February 11, 2019

   · 

  10 min read
• Deals

  VIASPACE Plans to Complete Acquisition of Elite Therapeutics

  VIASPACE, Inc. announced that it now plans to complete the acquisition of luxury cosmetics company Elite Therapeutics.

  February 11, 2019

   · 

  3 min read
• BioForest

  CTI BioPharma Receives $10 Million Milestone Payment for TRISENOX®

  CTI BioPharma Corp. announced that it has received a $10 million milestone payment from Teva Pharmaceutical Industries Ltd.

  February 11, 2019

   · 

  2 min read
• Drug Development

  Concert Pharmaceuticals Selected for Late-Breaking Oral Presentation of CTP-543 Phase 2 Data in Alopecia Areata at 2019 AAD Annual Meeting

  Concert Pharmaceuticals, Inc. announced that interim clinical data from its CTP-543 Phase 2 trial in alopecia areata has been selected for an oral presentation at the Late-Breaking Research Program during the American Academy of Dermatology Annual Meeting being held March 1 - 5, 2019 in Washington, D.C.

  February 11, 2019

   · 

  4 min read
• Deals

  Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange

  Cannara Biotech Inc., a vertically integrated cannabis company focused on cultivation and cannabis-infused products, announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol “8CB”.

  February 11, 2019

   · 

  2 min read
• Pharm Country

  Civica integrates VisionWare - announces enhanced capabilities in the US healthcare and state and local government markets

  Full integration coincides with launch of the latest version of leading MDM technology solution, MultiVue

  February 11, 2019

   · 

  2 min read
• Business

  Hyland Healthcare Brings New Solutions, Expert Speakers and Interoperability Demonstrations to HIMSS19

  Hyland Healthcare, a leading global provider of connected healthcare solutions, will demonstrate how to “see your whole patient” at HIMSS19.

  February 11, 2019

   · 

  3 min read